NINA ZEGLER: Open Payments
NPI 1942773056 · FALLON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 11 payments from 8 companies in 2025. Trend: 2023 $314 · 2024 $509 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $113 |
| GlaxoSmithKline, LLC. | 2 | $53 |
| ABBVIE INC. | 2 | $43 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $32 |
| Amgen Inc. | 1 | $28 |
| Alkermes, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| SANOFI PASTEUR INC. | 1 | $17 |
Products named: ETERNA, VRAYLAR, SHINGRIX, JOURNAVX, KRYSTEXXA, VIVITROL, MOUNJARO, BEXSERO.
Industry payments across NV — which companies pay providers there.
